Fat embolism syndrome pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Feham Tariq (talk | contribs) |
Feham Tariq (talk | contribs) |
||
| Line 11: | Line 11: | ||
*Mechanical theory | *Mechanical theory | ||
*Biochemical theory | *Biochemical theory | ||
===Mechanical theory=== | |||
The theory proposes that there is mechanical obstruction by fat cells from the bone marrow in the end-capillaries after trauma. | The theory proposes that there is mechanical obstruction by fat cells from the bone marrow in the end-capillaries after trauma. | ||
| Line 21: | Line 21: | ||
*Fat cells may also enter the arterial circulation via a patent foramen ovale or directly through the pulmonary capillary bed, causing the characteristic neurological and dermatologic findings of FES | *Fat cells may also enter the arterial circulation via a patent foramen ovale or directly through the pulmonary capillary bed, causing the characteristic neurological and dermatologic findings of FES | ||
===Biochemical theory=== | |||
This theory attributes the clinical manifestations of FES to the pro inflammatory effect of fat emboli.<ref name="pmid16990064">{{cite journal| author=Husebye EE, Lyberg T, Røise O| title=Bone marrow fat in the circulation: clinical entities and pathophysiological mechanisms. | journal=Injury | year= 2006 | volume= 37 Suppl 4 | issue= | pages= S8-18 | pmid=16990064 | doi=10.1016/j.injury.2006.08.036 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16990064 }} </ref><ref name="pmid9686075">{{cite journal| author=Estèbe JP| title=[From fat emboli to fat embolism syndrome]. | journal=Ann Fr Anesth Reanim | year= 1997 | volume= 16 | issue= 2 | pages= 138-51 | pmid=9686075 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9686075 }} </ref><ref name="pmid7753543">{{cite journal| author=Hofmann S, Huemer G, Kratochwill C, Koller-Strametz J, Hopf R, Schlag G et al.| title=[Pathophysiology of fat embolisms in orthopedics and traumatology]. | journal=Orthopade | year= 1995 | volume= 24 | issue= 2 | pages= 84-93 | pmid=7753543 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7753543 }} </ref> | This theory attributes the clinical manifestations of FES to the pro inflammatory effect of fat emboli.<ref name="pmid16990064">{{cite journal| author=Husebye EE, Lyberg T, Røise O| title=Bone marrow fat in the circulation: clinical entities and pathophysiological mechanisms. | journal=Injury | year= 2006 | volume= 37 Suppl 4 | issue= | pages= S8-18 | pmid=16990064 | doi=10.1016/j.injury.2006.08.036 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16990064 }} </ref><ref name="pmid9686075">{{cite journal| author=Estèbe JP| title=[From fat emboli to fat embolism syndrome]. | journal=Ann Fr Anesth Reanim | year= 1997 | volume= 16 | issue= 2 | pages= 138-51 | pmid=9686075 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9686075 }} </ref><ref name="pmid7753543">{{cite journal| author=Hofmann S, Huemer G, Kratochwill C, Koller-Strametz J, Hopf R, Schlag G et al.| title=[Pathophysiology of fat embolisms in orthopedics and traumatology]. | journal=Orthopade | year= 1995 | volume= 24 | issue= 2 | pages= 84-93 | pmid=7753543 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7753543 }} </ref> | ||
| Line 27: | Line 27: | ||
** '''Free fatty acids''': | ** '''Free fatty acids''': | ||
Free fatty acids are released into the circulation after hydrolysis and deposit into the end capillaries of the lung, manifesting as acute respiratory distress syndrome. | Free fatty acids are released into the circulation after hydrolysis and deposit into the end capillaries of the lung, manifesting as acute respiratory distress syndrome. | ||
* '''Cytokines:''' | ** '''Cytokines:''' | ||
Patients with FES are also found to have high levels of certain cytokines such as tumor necrosis factor alpha, Phospholipase A2, interleukin 1 and 6. | Patients with FES are also found to have high levels of certain cytokines such as tumor necrosis factor alpha, Phospholipase A2, interleukin 1 and 6. | ||
** '''C-reactive proteins:''' | ** '''C-reactive proteins:''' | ||
Revision as of 01:46, 4 March 2018
|
Fat embolism syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fat embolism syndrome pathophysiology On the Web |
|
American Roentgen Ray Society Images of Fat embolism syndrome pathophysiology |
|
Risk calculators and risk factors for Fat embolism syndrome pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Feham Tariq, MD [2]
Overview
Fat embolism syndrome (FES) is the presence of fat globules in the circulation post traumatic insult which can lodge into the small sized capillaries in the lung, brain and skin leading to devastating clinical manifestations. The two widely accepted theories which explain the pathophysiology of FES are mechanical and biochemical theory.
Pathophysiology
Two major theories have been described to explain the pathophysiology of fat embolism syndrome(FES):[1][2]
- Mechanical theory
- Biochemical theory
Mechanical theory
The theory proposes that there is mechanical obstruction by fat cells from the bone marrow in the end-capillaries after trauma.
- Post traumatic insult, the fat cells travel via venous sinusoids to the capillaries.
- These cells have potent prothrombotic and proinflammatory potential.
- They trigger rapid aggregation of platelets and accelerated fibrin generation as they travel through the venous system, eventually lodging in the pulmonary arterial circulation.
- Pulmonary capillary obstruction leads to interstitial hemorrhage and edema, alveolar collapse, and reactive hypoxemic vasoconstriction.
- Massive fat emboli may also lead to macrovascular obstruction and shock.
- Fat cells may also enter the arterial circulation via a patent foramen ovale or directly through the pulmonary capillary bed, causing the characteristic neurological and dermatologic findings of FES
Biochemical theory
This theory attributes the clinical manifestations of FES to the pro inflammatory effect of fat emboli.[3][4][5]
- Tissue lipases break down the fat in the bone marrow, forming high levels of the following toxic intermediaries;
- Free fatty acids:
Free fatty acids are released into the circulation after hydrolysis and deposit into the end capillaries of the lung, manifesting as acute respiratory distress syndrome.
- Cytokines:
Patients with FES are also found to have high levels of certain cytokines such as tumor necrosis factor alpha, Phospholipase A2, interleukin 1 and 6.
- C-reactive proteins:
The elevation is c-reactive proteins is responsible for lipid agglutintion in FES which results in microvasculature obstruction and stagnant blood flow.
- Eventually, these intermediate products lead to end-organ dysfunction.
- In the lung, toxic injury to pneumocytes and pulmonary endothelial cells causes vasogenic and cytotoxic edema as well as hemorrhage.
- Acute lung injury or acute respiratory distress syndrome results from damaged pulmonary endothelium that triggers a proinflammatory cytokine cascade.
Video
{{#ev:youtube|eeAQ2akVjL8}}
Genetics
- There is no genetic association of FES.
Gross pathology
Microscopic pathology
Hematoxylin and eosin staining shows the following changes in the lungs, kidneys and brain:[6]
Lung:
- Alveolar haemorrhagic edema
- Fat droplet deposition
- Fibrin thrombi
- Multiple fat droplets
Immunohistochemical staining shows the following changes:
- Raised levels of iNOS in the alveolar macrophages.
Kidney:
- Hematoxylin and eosin staining shows fat deposits in the glomeruli.
Brain:
References
- ↑ Parisi DM, Koval K, Egol K (2002). "Fat embolism syndrome". Am J Orthop (Belle Mead NJ). 31 (9): 507–12. PMID 12650535.
- ↑ Robert JH, Hoffmeyer P, Broquet PE, Cerutti P, Vasey H (1993). "Fat embolism syndrome". Orthop Rev. 22 (5): 567–71. PMID 8316420.
- ↑ Husebye EE, Lyberg T, Røise O (2006). "Bone marrow fat in the circulation: clinical entities and pathophysiological mechanisms". Injury. 37 Suppl 4: S8–18. doi:10.1016/j.injury.2006.08.036. PMID 16990064.
- ↑ Estèbe JP (1997). "[From fat emboli to fat embolism syndrome]". Ann Fr Anesth Reanim. 16 (2): 138–51. PMID 9686075.
- ↑ Hofmann S, Huemer G, Kratochwill C, Koller-Strametz J, Hopf R, Schlag G; et al. (1995). "[Pathophysiology of fat embolisms in orthopedics and traumatology]". Orthopade. 24 (2): 84–93. PMID 7753543.
- ↑ . doi:10.1042/CS2007001. Missing or empty
|title=(help)